Drug-related problems and pharmacy interventions in community practice

International Journal of Pharmacy Practice

Volumn 7, Issue 1, 1999, Pages 40-50

  Westerlund, Tommy ^a   Almarsdóttir, Anna Birna ^b   Melander, Arne ^c  

^a Apoteket AB   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY CARE; GENDER; HOSPITAL PHARMACY; HUMAN; OUTPATIENT; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT INFORMATION; PHARMACY; PRIORITY JOURNAL; SWEDEN;

EID: 0032893951     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1999.tb00947.x     Document Type: Article

References (24)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. Pharmaceutical care: The Minnesota model. Pharm J 1997;258:899-904.
3. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill 1998;19-26.
4. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice Ibid;78-80.
5. Berardo DH, Kimberlin CL, McKenzie LC, Pendergast JF. Community pharmacists' documentation of intervention on drug related problems of elderly patients. J Soc Admin Pharm 1994;11:182-93.
6. Plushner SL, Helling DK, Becka A. Identifying drug-related problems (DRPs) in geriatric members of a health maintenance organization. ASHP Annual Meeting 1993;50; IPC-17.
7. Woollett LM, MacKeigan L, Schneider PJ, Finley D. Detection of drug-related problems in an ambulatory pharmacy. ASHP Annual Meeting Ibid; P-91R
8. Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the pharmaceutical care project in Minnesota. Am Pharm 1995;NS35:30-9.
9. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill 1998;205-235.
10. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992;30:926-40.
11. Rupp MT. The value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 1992;26:1580-4.
12. Rogers PJ, Fletcher G, Rees JE. Clinical interventions by community pharmacists using patient medication records. Int J Pharm Pract 1994;3:6-13.
13. Claesson C, Burman K, Nilsson JLG, Vinge E. Prescription errors detected by Swedish pharmacists. Int J Pharm Pract Ibid 1995;3:151-6.
14. Greene R. Survey of prescription anomalies in community pharmacies: (1) Prescription monitoring. Pharm J 1995;254:476-81.
15. Greene R. Survey of prescription anomalies in community pharmacies: (2) Interventions and outcomes. Pharm J Ibid 1995;254:873-5.
16. Caleo S, Benrimoj S, Collins D, Lauchlan R, Stewart K. Clinical evaluation of community pharmacists' interventions. Int J Pharm Pract 1996;4:221-7.
17. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997;277:312-7.
18. Strand LM, Morley PC, Cipolle RJ et al. Drug-related problems: their structure and function. Ann Pharmacother 1990;24:1093-7.
19. Segal R. Therapeutic outcomes monitoring: a method for implementing pharmaceutical care. In: Escovitz A, Pathak DS, editors. Health outcomes and pharmaceutical care: measurement, applications, and initiatives. New York: Pharmaceutical Products Press (an imprint of the Haworth Press, Inc), 1996: 193-8.
20. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics, 1996.
21. ATC index with DDDs. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1997.
22. Lunde PKM, Baksaas Aaasen I, Halse M, Halvorsen IK, Strömnes BD, Oydvin K. The methodology of drug utilization studies. In: Bergman U, Grimsson A, Wahba AHW, Westerholm B, editors. Studies in drug utilization: Methods and applications. European Series, No 8. Copenhagen: WHO Regional Publ, 1979:17-28.
23. Capella D. Descriptive tools and analyses. In: Dukes MNG, editor. Drug utilization studies: Methods and uses. European Series, No 45. Copenhagen: WHO Regional Publ, 1993.
24. Stevens RG, Balon D. Detection of hazardous drug/drug interactions in a community pharmacy and subsequent intervention. Int J Pharm Pract 1997;5:142-8.